Nalaganje...
Treatment of early-stage HER2+ breast cancer—an evolving field
The evolving field of HER2-targeted therapy has significantly improved the outcome of women diagnosed with HER2-positive invasive breast cancer. In this review, we sought to summarise the efficacy of trastuzumab-based regimens in the adjuvant and neoadjuvant setting with a special emphasis on releva...
Shranjeno v:
| izdano v: | Ecancermedicalscience |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Cancer Intelligence
2015
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4406526/ https://ncbi.nlm.nih.gov/pubmed/25932047 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2015.523 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|